![Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents | British Journal of Cancer Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2012.357/MediaObjects/41416_2012_Article_BFbjc2012357_Fig1_HTML.jpg)
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents | British Journal of Cancer
![Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology - Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -](https://bpspubs.onlinelibrary.wiley.com/cms/asset/ca2685cb-d6e2-4a06-b515-6e38b2a2e629/bcp13982-fig-0003-m.jpg)
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -
![Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity - ScienceDirect Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804917307359-gr1.jpg)
Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity - ScienceDirect
![Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer - ScienceDirect Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221004984-ga1.jpg)
Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer - ScienceDirect
![Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer | Journal for ImmunoTherapy of Cancer Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/2/e002100/F7.large.jpg)
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer | Journal for ImmunoTherapy of Cancer
![Paclitaxel | CAS:33069-62-4 | Antineoplastic agent | Diterpenoids | High Purity | Manufacturer BioCrick Paclitaxel | CAS:33069-62-4 | Antineoplastic agent | Diterpenoids | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCN4650.png)
Paclitaxel | CAS:33069-62-4 | Antineoplastic agent | Diterpenoids | High Purity | Manufacturer BioCrick
![Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology - Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -](https://bpspubs.onlinelibrary.wiley.com/cms/asset/2639506e-55c5-4b54-b453-ec3762a5deff/bcp13982-fig-0001-m.jpg)
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -
![Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer - Gota - 2021 - Cancer Medicine - Wiley Online Library Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer - Gota - 2021 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a7ac8b4c-241f-4a23-a139-dcd9edbb0ff6/cam43865-toc-0001-m.jpg?trick=1662419802011)